(Q42953702)

11 November 2017

title

An observational study of methionine-bound zinc with antioxidants for mild to moderate acne vulgaris (English)

1 reference

11 November 2017

Kabir Sardana

1

1 reference

11 November 2017

Vijay K. Garg

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20666829

12 June 2024

language of work or name

1 reference

1 July 2010

1 reference

full work available at URL

11 November 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1529-8019.2010.01342.x

1 reference

https://api.crossref.org/works/10.1111/J.1529-8019.2010.01342.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1529-8019.2010.01342.x/fullpdf

12 June 2024

1 reference

https://api.crossref.org/works/10.1111/J.1529-8019.2010.01342.X

12 June 2024

1 reference

11 November 2017

volume

23

1 reference

11 November 2017

issue

4

1 reference

11 November 2017

page(s)

411-418

1 reference

The role of the antioxidative defense system in papulopustular acne.

11 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2010.01342.X

A double-blind study of the effect of zinc and oxytetracycline in acne vulgaris

21 January 2018

2

1 reference

https://api.crossref.org/works/10.1111/J.1529-8019.2010.01342.X

Effects of Oral Zinc and Vitamin A in Acne

12 June 2024

3

1 reference

https://api.crossref.org/works/10.1111/J.1529-8019.2010.01342.X

A double-blind trial of a zinc sulphate/citrate complex and tetracycline in the treatment of acne vulgaris

12 June 2024

8

1 reference

https://api.crossref.org/works/10.1111/J.1529-8019.2010.01342.X

Oral zinc sulphate therapy in acne vulgaris: a double-blind trial

12 June 2024

9

1 reference

https://api.crossref.org/works/10.1111/J.1529-8019.2010.01342.X

Efficacy and safety study of two zinc gluconate regimens in the treatment of inflammatory acne

12 June 2024

11

1 reference

https://api.crossref.org/works/10.1111/J.1529-8019.2010.01342.X

Multicenter randomized comparative double-blind controlled clinical trial of the safety and efficacy of zinc gluconate versus minocycline hydrochloride in the treatment of inflammatory acne vulgaris

12 June 2024

12

1 reference

https://api.crossref.org/works/10.1111/J.1529-8019.2010.01342.X

Methodology for assessing zinc bioavailability: efficacy estimates for zinc-methionine, zinc sulfate, and zinc oxide

12 June 2024

13

1 reference

https://api.crossref.org/works/10.1111/J.1529-8019.2010.01342.X

Serum zinc levels in Iranian patients with acne

12 June 2024

15

1 reference

https://api.crossref.org/works/10.1111/J.1529-8019.2010.01342.X

Zinc salts in dermatology

12 June 2024

17

1 reference

https://api.crossref.org/works/10.1111/J.1529-8019.2010.01342.X

Inhibition of 5 alpha-reductase activity in human skin by zinc and azelaic acid

12 June 2024

19

1 reference

https://api.crossref.org/works/10.1111/J.1529-8019.2010.01342.X

The effect of zinc on the 5α-reduction of testosterone by the hyperplastic human prostate gland

12 June 2024

20

1 reference

https://api.crossref.org/works/10.1111/J.1529-8019.2010.01342.X

The 5 alpha-reductase system and its inhibitors. Recent development and its perspective in treating androgen-dependent skin disorders

12 June 2024

21

1 reference

https://api.crossref.org/works/10.1111/J.1529-8019.2010.01342.X

Selective inhibition of steroid 5 alpha-reductase isozymes by tea epicatechin-3-gallate and epigallocatechin-3-gallate

12 June 2024

22

1 reference

https://api.crossref.org/works/10.1111/J.1529-8019.2010.01342.X

Inhibition of 5 alpha-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids

12 June 2024

23

1 reference

https://api.crossref.org/works/10.1111/J.1529-8019.2010.01342.X

Acne treatment with topical erythromycin and zinc: Effect on Propionibacterium acnes and free fatty acid composition

12 June 2024

25

1 reference

https://api.crossref.org/works/10.1111/J.1529-8019.2010.01342.X

Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study

12 June 2024

26

1 reference

https://api.crossref.org/works/10.1111/J.1529-8019.2010.01342.X

Inhibition of some functions of polymorphonuclear leukocytes by in vitro zinc

12 June 2024

27

1 reference

https://api.crossref.org/works/10.1111/J.1529-8019.2010.01342.X

Comparative study of the in vitro inflammatory activity of three nickel salts on keratinocytes

12 June 2024

28

1 reference

https://api.crossref.org/works/10.1111/J.1529-8019.2010.01342.X

In vitro modulation of keratinocyte wound healing integrins by zinc, copper and manganese

12 June 2024

29

1 reference

https://api.crossref.org/works/10.1111/J.1529-8019.2010.01342.X

Zinc, copper and manganese enhanced keratinocyte migration through a functional modulation of keratinocyte integrins

12 June 2024

30

1 reference

https://api.crossref.org/works/10.1111/J.1529-8019.2010.01342.X

Zinc salts inhibit in vitro Toll-like receptor 2 surface expression by keratinocytes

12 June 2024

32

1 reference

https://api.crossref.org/works/10.1111/J.1529-8019.2010.01342.X

Toll-like receptors in the induction of the innate immune response

12 June 2024

33

1 reference

https://api.crossref.org/works/10.1111/J.1529-8019.2010.01342.X

Review of the innate immune response in acne vulgaris: activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses

12 June 2024

34

1 reference

https://api.crossref.org/works/10.1111/J.1529-8019.2010.01342.X

Induction of toll-like receptors by Propionibacterium acnes

12 June 2024

35

1 reference

https://api.crossref.org/works/10.1111/J.1529-8019.2010.01342.X

Oxidative stress in patients with acne vulgaris

12 June 2024

37

1 reference

https://api.crossref.org/works/10.1111/J.1529-8019.2010.01342.X

The possible role of reactive oxygen species generated by neutrophils in mediating acne inflammation

12 June 2024

39

1 reference

https://api.crossref.org/works/10.1111/J.1529-8019.2010.01342.X

Increased hydrogen peroxide generation by neutrophils from patients with acne inflammation

12 June 2024

42

1 reference

https://api.crossref.org/works/10.1111/J.1529-8019.2010.01342.X

Acne vulgaris: correcting pathophysiologic defects versus antibacterial therapy

12 June 2024

43

1 reference

https://api.crossref.org/works/10.1111/J.1529-8019.2010.01342.X

Does the plasma level of vitamins A and E affect acne condition?

12 June 2024

45

1 reference

https://api.crossref.org/works/10.1111/J.1529-8019.2010.01342.X

Antibiotic-resistant acne: lessons from Europe

12 June 2024

48

1 reference

https://api.crossref.org/works/10.1111/J.1529-8019.2010.01342.X

Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study

12 June 2024

50

1 reference

https://api.crossref.org/works/10.1111/J.1529-8019.2010.01342.X

Bioavailability, antioxidant and immune-enhancing properties of zinc methionine

12 June 2024

51

1 reference

https://api.crossref.org/works/10.1111/J.1529-8019.2010.01342.X

Systemic Antibiotics for Treatment of Acne Vulgaris

12 June 2024

53

1 reference

https://api.crossref.org/works/10.1111/J.1529-8019.2010.01342.X

Efficacy of fixed low-dose isotretinoin (20 mg, alternate days) with topical clindamycin gel in moderately severe acne vulgaris

12 June 2024

54

1 reference

https://api.crossref.org/works/10.1111/J.1529-8019.2010.01342.X

Acne vulgaris: correcting pathophysiologic defects versus antibacterial therapy

12 June 2024

56

1 reference

https://api.crossref.org/works/10.1111/J.1529-8019.2010.01342.X

12 June 2024

Identifiers

1 reference

11 November 2017

1 reference